Austedo 12 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26F88LK
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,352
Award facts
- Contract value 100% obligated
- $14,352.38 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 9, 2026, the Defense Logistics Agency awarded a delivery order valued at $14,352.38 to AmerisourceBergen Drug Corp for 60 tablets of Austedo 12 mg, a medication used to treat involuntary movement disorders. This firm fixed-price delivery order, with an ultimate completion date of January 12, 2026, represents a non-competitive set-aside award issued against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor that serves as a critical vendor for federal medical procurement needs.
This delivery order falls under AmerisourceBergen's comprehensive $999,999,999.00 IDC with DLA Troop Support Medical (designated SPE2DX), which extends through December 2026 and provides global pharmaceutical support to military healthcare programs. The IDC enables the company to supply a broad range of pharmaceutical products and medical commodities across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The parent company, Cencora, Inc., maintains an even larger IDC with DLA valued at up to $999,999,999.00 through December 31, 2031, underscoring the company's significant role in supplying essential medications and medical supplies to federal defense and healthcare operations.
Quick answers
Who was awarded contract SPE2DR26F88LK?
SPE2DR26F88LK was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 9, 2026.
How much is contract SPE2DR26F88LK worth?
The government has obligated $14,352 on SPE2DR26F88LK.
Is contract SPE2DR26F88LK an order under another contract?
Yes. SPE2DR26F88LK is a delivery order under SPE2DR25D3010, an indefinite delivery contract.
Was contract SPE2DR26F88LK competed?
The extent of competition for SPE2DR26F88LK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award